Skip to content
Isoniazid
Hyzyd, Inh, Laniazid, Nydrazid, Rifamate, Rifater, Rimifon, Stanozide (isoniazid) is a small molecule pharmaceutical. Isoniazid was first approved as Nydrazid on 1982-01-01. It is used to treat mycobacterium infections and tuberculosis in the USA.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Isoniazid
Tradename
Company
Number
Date
Products
NYDRAZIDBristol Myers SquibbN-008392 DISCN1982-01-01
1 products
ISONIAZIDEpic PharmaN-008678 DISCN1982-01-01
2 products, RLD
ISONIAZIDEli LillyN-008499 DISCN1982-01-01
2 products
ISONIAZIDPanray CorporationN-008428 DISCN1982-01-01
3 products
RIMIFONRocheN-008420 DISCN1982-01-01
3 products
NYDRAZIDSandozN-008662 DISCN1982-01-01
1 products
Hide discontinued
Isoniazid
+
Pyrazinamide
+
Rifampin
Tradename
Company
Number
Date
Products
RIFATERSanofiN-050705 DISCN1994-05-31
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
isoniazidANDA2023-06-07
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
mycobacterium infectionsD009164A31.9
tuberculosisEFO_0000774D014376A15-A19
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
J04: Antimycobacterials
J04A: Drugs for treatment of tuberculosis
J04AC: Hydrazides for tuberculosis treatment
J04AC01: Isoniazid
J04AC51: Isoniazid, combinations
J04AM: Combinations of drugs for treatment of tuberculosis
J04AM01: Streptomycin and isoniazid
J04AM02: Rifampicin and isoniazid
J04AM03: Ethambutol and isoniazid
J04AM04: Thioacetazone and isoniazid
J04AM05: Rifampicin, pyrazinamide and isoniazid
J04AM06: Rifampicin, pyrazinamide, ethambutol and isoniazid
J04AM07: Rifampicin, ethambutol and isoniazid
J04AM08: Isoniazid, sulfamethoxazole, trimethoprim and pyridoxine
HCPCS
No data
Clinical
Clinical Trials
150 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TuberculosisD014376EFO_0000774A15-A19142222111576
Hiv infectionsD015658EFO_0000764B203676827
Pulmonary tuberculosisD014397EFO_1000049A151095527
Latent tuberculosisD055985Z22.73286219
Diabetes mellitusD003920EFO_0000400E08-E13123
HepatitisD006505HP_0012115K75.922
Hiv seropositivityD0066791112
Opioid-related disordersD009293EFO_0005611F1111
Type 2 diabetes mellitusD003924EFO_0001360E1111
AlcoholismD000437EFO_0003829F10.111
Show 6 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HivD006678O98.712418
Multidrug-resistant tuberculosisD018088EFO_00073811256
Extensively drug-resistant tuberculosisD054908122
Anterior uveitisD014606EFO_100081111
Acquired immunodeficiency syndromeD000163EFO_0000765B20111
InfectionsD007239EFO_000054411
Female infertilityD007247EFO_0008560N9711
Female genital tuberculosisD014384EFO_100093511
Male genital tuberculosisD014389EFO_100103011
Pneumocystis pneumoniaD011020EFO_0007448B59111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Meningeal tuberculosisD014390A17.0112
PregnancyD011247EFO_0002950Z33.1111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug-related side effects and adverse reactionsD064420T88.7112
Drug interactionsD00434711
MelanomaD00854511
Healthy volunteers/patients11
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Body weight changesD00183611
Motor activityD009043EFO_000394011
SilicotuberculosisD012830J6511
Erythropoietic protoporphyriaD046351E80.011
Chemical and drug induced liver injuryD05648611
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameISONIAZID
INNisoniazid
Description
Isoniazide is a carbohydrazide obtained by formal condensation between pyridine-4-carboxylic acid and hydrazine. It has a role as an antitubercular agent and a drug allergen. It is functionally related to an isonicotinic acid.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
NNC(=O)c1ccncc1
Identifiers
PDB
CAS-ID54-85-3
RxCUI6038
ChEMBL IDCHEMBL64
ChEBI ID6030
PubChem CID3767
DrugBankDB00951
UNII IDV83O1VOZ8L (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 36,478 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
12,976 adverse events reported
View more details